Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Oct-23 8:54 AM View:  | Schuyler Kevin Director | Adial Pharmaceuticals, Inc. (ADIL) | 29-Sep-23 | Market Purchase | 700 | $2.74 | $1,918.00 | 12% 5.89K to 6.59K | (4%) |
| 25-May-23 4:47 PM View: | Stilley William B. III Director | Adial Pharmaceuticals, Inc. (ADIL) | 23-May-23 | Grant | 240,800 | -- | -- | 24% 1.02M to 1.26M | |
| 25-May-23 4:36 PM View: | Claiborne Cary J Chief Executive Officer Director | Adial Pharmaceuticals, Inc. (ADIL) | 23-May-23 | Grant | 420,000 | -- | -- | 38% 1.1M to 1.52M | |
| 25-May-23 4:50 PM View: | Truluck Joseph Chief Financial Officer | Adial Pharmaceuticals, Inc. (ADIL) | 23-May-23 | Grant | 157,500 | -- | -- | 146% 107.64K to 265.14K | |
| 03-Jan-23 6:02 AM View: | Stilley William B. III Director | Adial Pharmaceuticals, Inc. (ADIL) | 30-Dec-22 | Disposition | 166,667 | -- | -- | (14%) 1.19M to 1.02M | |
| 20-Sep-22 7:11 PM View: | Claiborne Cary J Chief Executive Officer Director | Adial Pharmaceuticals, Inc. (ADIL) | 20-Sep-22 | Grant | 75,000 | $0.42 | $31,515.00 | 7% 1.02M to 1.1M | |
| 20-Sep-22 7:11 PM View: | Claiborne Cary J Chief Executive Officer Director | Adial Pharmaceuticals, Inc. (ADIL) | 19-Sep-22 | Grant | 25,000 | $0.43 | $10,735.00 | 3% 1000.0K to 1.02M | |
| 22-Aug-22 4:42 PM View: | Claiborne Cary J Chief Executive Officer | Adial Pharmaceuticals, Inc. (ADIL) | 18-Aug-22 | Grant | 1,000,000 | -- | -- | 100% 0 to 1000.0K | |
| 25-Feb-22 3:00 PM View: | Stilley William B. III Chief Executive Officer Director | Adial Pharmaceuticals, Inc. (ADIL) | 23-Feb-22 | Grant | 250,000 | -- | -- | 27% 937.65K to 1.19M | |
| 03-Jan-22 10:39 AM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 30-Dec-21 | Market Purchase | 10,000 | $2.66 | $26,600.00 | 3% 313.46K to 323.46K | (1%) |
| 03-Jan-22 10:39 AM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 30-Dec-21 | Market Purchase | 15,000 | $2.71 | $40,700.00 | 5% 323.46K to 338.46K | (3%) |
| 23-Dec-21 5:04 PM View: | Schuyler Kevin Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 23-Dec-21 | Gift | 312,990 | -- | -- | (68%) 460.23K to 147.24K | |
| 01-Dec-21 9:25 AM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 30-Nov-21 | Market Purchase | 10,600 | $2.75 | $29,178.60 | 1% 927.05K to 937.65K | < 1% |
| 01-Dec-21 9:25 AM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 29-Nov-21 | Market Purchase | 10,000 | $2.59 | $25,892.00 | 1% 917.05K to 927.05K | 7% |
| 30-Nov-21 9:25 AM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 26-Nov-21 | Market Purchase | 10,000 | $2.85 | $28,500.00 | 3% 303.46K to 313.46K | (10%) |
| 06-Oct-21 5:22 PM View: | Johnson Bankole A. Chief Medical Officer | Adial Pharmaceuticals, Inc. (ADIL) | 04-Oct-21 | Sale | 200,000 | -- | -- | (57%) 348.25K to 148.25K | |
| 08-Apr-21 9:47 PM View: | Johnson Bankole A. Chief Medical Officer | Adial Pharmaceuticals, Inc. (ADIL) | 06-Apr-21 | Market Sale | 150,000 | $2.50 | $375,000.00 | (17%) 874.47K to 724.47K | (48%) |
| 28-Jan-21 7:44 PM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 26-Jan-21 | Grant | 3,731 | -- | -- | 1% 269.73K to 273.46K | |
| 28-Jan-21 7:45 PM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 26-Jan-21 | Grant | 201,109 | -- | -- | 28% 715.94K to 917.05K | |
| 24-Aug-20 4:59 PM View: | Johnson Bankole A. Chief Medical Officer | Adial Pharmaceuticals, Inc. (ADIL) | 20-Aug-20 | Sale | 350,000 | $1.21 | $423,500.00 | (29%) 1.22M to 874.47K | |
| 30-Mar-20 9:23 AM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 27-Mar-20 | Market Purchase | 5,000 | $1.42 | $7,100.00 | 2% 250.09K to 255.09K | 158% |
| 30-Mar-20 9:23 AM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 27-Mar-20 | Market Purchase | 14,644 | $1.34 | $19,669.40 | 6% 255.09K to 269.73K | 173% |
| 27-Mar-20 6:03 AM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 26-Mar-20 | Market Purchase | 12,652 | $1.47 | $18,598.40 | 2% 703.28K to 715.94K | 149% |
| 27-Mar-20 6:03 AM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 25-Mar-20 | Market Purchase | 12,348 | $1.13 | $13,953.20 | 2% 690.94K to 703.28K | 224% |
| 05-Mar-20 7:20 PM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 03-Mar-20 | Grant | 54,167 | -- | -- | 9% 636.77K to 690.94K | |
| 05-Mar-20 7:19 PM View: | Truluck Joseph Chief Financial Officer Director | Adial Pharmaceuticals, Inc. (ADIL) | 03-Mar-20 | Grant | 27,084 | -- | -- | 34% 80.56K to 107.64K | |
| 13-Dec-19 9:00 PM View: | Johnson Bankole A. Chief Medical Officer 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 12-Dec-19 | Sale | 150,000 | $1.00 | $150,000.00 | (11%) 1.37M to 1.22M | |
| 04-Oct-19 5:01 PM View: | Johnson Bankole A. Chief Medical Officer 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 02-Oct-19 | Grant | 3,187 | -- | -- | < 1% 1.37M to 1.37M | |
| 01-Apr-19 4:57 PM View: | Johnson Bankole A. Chief Medical Officer 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 29-Mar-19 | Market Purchase | 33,100 | $3.47 | $114,801.00 | 2% 1.34M to 1.37M | 5% |
| 01-Apr-19 4:57 PM View: | Johnson Bankole A. Chief Medical Officer 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 28-Mar-19 | Market Purchase | 40,000 | $3.15 | $125,808.00 | 3% 1.3M to 1.34M | 16% |
| 02-Aug-18 4:11 PM View: | Schuyler Kevin Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Acquisition (other) | 120,000 | -- | -- | 88% 136.43K to 256.43K | |
| 02-Aug-18 4:14 PM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Acquisition (other) | 36,800 | -- | -- | 7% 519.34K to 556.14K | |
| 02-Aug-18 4:16 PM View: | Truluck Joseph Chief Financial Officer | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Conversion | 5,927 | -- | -- | 8% 74.63K to 80.56K | |
| 02-Aug-18 4:08 PM View: | Johnson Bankole A. Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Conversion | 153,114 | $0.44 | $67,370.20 | 14% 1.13M to 1.28M | |
| 02-Aug-18 4:10 PM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Purchase | 10,000 | -- | -- | 3% 367.09K to 377.09K | |
| 02-Aug-18 4:11 PM View: | Schuyler Kevin Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Acquisition (other) | 113,800 | -- | -- | 44% 256.43K to 370.23K | |
| 02-Aug-18 4:14 PM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Purchase | 80,000 | -- | -- | 14% 556.14K to 636.14K | |
| 02-Aug-18 4:03 PM View: | Gilliland Robertson H. Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Conversion | 29,931 | -- | -- | 46% 65.49K to 95.42K | |
| 02-Aug-18 4:06 PM View: | Goodman Tony Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Purchase | 7,000 | -- | -- | 399% 1.75K to 8.76K | |
| 02-Aug-18 4:08 PM View: | Johnson Bankole A. Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Acquisition (other) | 17,600 | -- | -- | 1% 1.28M to 1.3M | |
| 02-Aug-18 4:10 PM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Conversion | 56,824 | -- | -- | 29% 198.27K to 255.09K | |
| 02-Aug-18 4:10 PM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Purchase | 10,000 | -- | -- | 3% 377.09K to 387.09K | |
| 02-Aug-18 4:11 PM View: | Schuyler Kevin Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Conversion | 82,461 | -- | -- | 153% 53.97K to 136.43K | |
| 02-Aug-18 4:11 PM View: | Schuyler Kevin Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Purchase | 90,000 | -- | -- | 24% 370.23K to 460.23K | |
| 02-Aug-18 4:14 PM View: | Stilley William B. III Chief Executive Officer Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Conversion | 52,227 | -- | -- | 11% 467.11K to 519.34K | |
| 02-Aug-18 4:03 PM View: | Gilliland Robertson H. Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Purchase | 14,000 | -- | -- | 15% 95.42K to 109.42K | |
| 02-Aug-18 4:08 PM View: | Johnson Bankole A. Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Grant | 40,382 | -- | -- | 4% 1.09M to 1.13M | |
| 02-Aug-18 4:08 PM View: | Johnson Bankole A. Director 10% Owner | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Purchase | 1,400 | -- | -- | < 1% 1.3M to 1.3M | |
| 02-Aug-18 4:10 PM View: | Newman James W. Jr. Director | Adial Pharmaceuticals, Inc. (ADIL) | 31-Jul-18 | Acquisition (other) | 112,000 | -- | -- | 44% 255.09K to 367.09K |
